Last, but not least, in the 1990s, an antimicrobial drug called triclosan, 5-chloro-2-(2,4-dichlorophenoxy)phenol, has been shown to have a cytotoxic effect against cancer cells and to be a potential FAS inhibitor [107]. This evidence concerns the gene FAS and cancer.